[ Price : $8.95]
Novartis and Bristol Myers Squibb confirm to BioSpace that they are suspending some CAR T candidate trials to evaluate adverse eve...[ Price : $8.95]
FDA adds a new frequently asked questions section to its Web page on PFAS (per- and polyfluoroalkyl substances) in medical devices...[ Price : $8.95]
FDA releases a draft guidance entitled Pharmacokinetics in Patients with Impaired Hepatic Function: Study Design, Data Analysis, a...[ Price : $8.95]
IDEAYA Biosciences says it had a successful FDA Type C meeting to determine the Phase 3 rial design for IDE849 for treating extens...[ Price : $8.95]
Karyopharm Therapeutics files a supplemental NDA seeking accelerated approval for Xpovio (selinexor) in combination with ruxolitin...[ Price : $8.95]
FDA and the U.S. Securities and Exchange Commission sign an MOU to strengthen cooperation and share information involving compani...[ Price : $8.95]
An appeals court appears to have raised the bar for generic drugmakers seeking to preserve 180-day marketing exclusivity after mis...[ Price : $8.95]
FDA and the International Coalition of Medicines Regulatory Authorities complete an assessment of a new biologics testing approach...